Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of ANXA1 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Goat |
| Applications | ELISA,WB-Ce,WB-Ti |
More info about ANXA1 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB11466 |
| Product name: | ANXA1 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of ANXA1. |
| Gene id: | 301 |
| Gene name: | ANXA1 |
| Gene alias: | ANX1|LPC1 |
| Gene description: | annexin A1 |
| Immunogen: | A synthetic peptide corresponding to human ANXA1. |
| Immunogen sequence/protein sequence: | CQAILDETKGDYEK |
| Protein accession: | NP_000691.1 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:32000) Western Blot (0.5-1.5 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | ANXA1 polyclonal antibody (Cat # PAB11466) (0.5 ug/mL) staining of A-431 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ce,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma.Paweletz CP, Ornstein DK, Roth MJ, Bichsel VE, Gillespie JW, Calvert VS, Vocke CD, Hewitt SM, Duray PH, Herring J, Wang QH, Hu N, Linehan WM, Taylor PR, Liotta LA, Emmert-Buck MR, Petricoin EF 3rd. Cancer Res. 2000 Nov 15;60(22):6293-7. |